Quick Answer
NEUROCRINE BIOSCIENCES INC reported Total Revenue of $2.86 billion for the year ending 2025.
- NEUROCRINE BIOSCIENCES INC showed an increase of +21.4% in Total Revenue from 2024 to 2025.
- This data is from NEUROCRINE BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on February 11, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.00 | Q3 2014: $0.00 | Q4 2014: $0.00 | Q1 2015: $19.77 million | Q2 2015: $0.00 | Q3 2015: $0.00 | Q4 2015: $0.00 | Q1 2016: $15.00 million | Q2 2016: $0.00 | Q3 2016: $0.00 | Q4 2016: $0.00 | Q1 2017: $0.00 | Q1 2017: $0.00 | Q2 2017: $6.34 million | Q2 2017: $6.34 million | Q3 2017: $60.77 million | Q3 2017: $60.77 million | Q4 2017: $94.52 million | Q4 2017: $94.52 million | Q1 2018: $71.09 million | Q1 2018: $71.09 million | Q2 2018: $96.91 million | Q2 2018: $96.91 million | Q3 2018: $151.76 million | Q4 2018: $131.49 million | Q1 2019: $138.40 million | Q2 2019: $183.50 million | Q3 2019: $222.10 million | Q4 2019: $244.10 million | Q1 2020: $237.10 million | Q2 2020: $302.40 million | Q3 2020: $258.50 million | Q4 2020: $247.90 million | Q1 2021: $236.60 million | Q2 2021: $288.90 million | Q3 2021: $296.00 million | Q1 2022: $310.60 million | Q2 2022: $378.20 million | Q3 2022: $387.90 million | Q1 2023: $420.40 million | Q2 2023: $452.70 million | Q3 2023: $498.80 million | Q1 2024: $515.30 million | Q2 2024: $590.20 million | Q3 2024: $622.10 million | Q1 2025: $572.60 million | Q2 2025: $687.50 million | Q3 2025: $794.90 million.
- Over the full 19 years of available data (2009 to 2025), NEUROCRINE BIOSCIENCES INC's Total Revenue has grown by 96,767.6%.
- Historical annual values: Fiscal year 2025: $2.86 billion | Fiscal year 2024: $2.36 billion | Fiscal year 2023: $1.89 billion | Fiscal year 2022: $1.49 billion | Fiscal year 2021: $1.13 billion | Fiscal year 2020: $1.05 billion | Fiscal year 2019: $788.10 million | Fiscal year 2018: $451.20 million | Fiscal year 2017: $161.63 million | Fiscal year 2017: $161.63 million | Fiscal year 2016: $15.00 million | Fiscal year 2016: $15.00 million | Fiscal year 2015: $19.77 million | Fiscal year 2014: $0.00 | Fiscal year 2013: $2.92 million | Fiscal year 2012: $53.14 million | Fiscal year 2011: $77.41 million | Fiscal year 2010: $33.50 million | Fiscal year 2009: $2.95 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: